Copyright
©The Author(s) 2019.
World J Gastroenterol. Jun 7, 2019; 25(21): 2650-2664
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2650
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2650
Variable | Study group (n = 189) | Validation group (n = 109) | P-value |
POPF | 0.976 | ||
No POPF | 117 (61.9) | 68 (62.4) | |
Grade A (BL) | 34 (18.0) | 18 (16.5) | |
Grade B | 32 (16.9) | 20 (18.3) | |
Grade C | 6 (3.2) | 3 (2.8) | |
Age (yr) | 61.8 ± 9.9 | 62.4 ± 10.3 | 0.650 |
Sex | 0.284 | ||
Male | 116 (61.4) | 60 (55.0) | |
Female | 73 (38.6) | 49 (45.0) | |
Surgery | 0.595 | ||
PD | 98 (51.9) | 60 (55.0) | |
PPPD | 91 (48.1) | 49 (45.0) | |
BMI (kg/m2) | 22.1 ± 2.9 | 22.4 ± 2.9 | 0.431 |
Diabetes mellitus | 0.164 | ||
Yes | 31 (16.4) | 25 (22.9) | |
No | 158 (83.6) | 84 (77.1) | |
Location of tumor | 0.493 | ||
Pancreas | 105 (55.6) | 65 (59.6) | |
Non-pancreas | 84 (44.4) | 44 (40.4) | |
Pathologic type | 0.834 | ||
Benign | 11 (5.8) | 7 (6.4) | |
Pancreatic myxoid cystadenoma | 7 (3.7) | 5 (4.6) | |
Pancreatic serous cystadenoma | 4 (2.1) | 2 (1.8) | |
Malignant | 178 (94.2) | 102 (93.6) | |
Pancreatic cancer | 92 (48.7) | 56 (51.4) | |
Biliary duct cancer | 29 (15.3) | 21 (19.3) | |
Ampullary cancer | 33 (17.5) | 16 (14.7) | |
Duodenal cancer | 24 (12.7) | 9 (8.3) | |
Preoperative STB (μmol/L) | 111.4 ± 120.4 | 116.0 ± 144.9 | 0.767 |
Preoperative pre-albumin (mg/L) | 141.2 ± 57.1 | 142.4 ± 56.8 | 0.861 |
Preoperative serum albumin (g/L) | 38.4 ± 5.7 | 37.5 ± 4.7 | 0.137 |
Preoperative serum globulin (g/L) | 26.9 ± 4.2 | 27.2 ± 4.9 | 0.606 |
Preoperative hemoglobin (g/L) | 121.4 ± 19.9 | 119.9 ± 19.5 | 0.533 |
Preoperative white blood cells (109/L) | 7.0 ± 8.1 | 6.4 ± 2.6 | 0.465 |
Preoperative platelets (109/L) | 233.7 ± 78.5 | 237.6 ± 73.7 | 0.671 |
Pancreatic texture | 0.725 | ||
Soft | 81 (42.9) | 49 (45.0) | |
Hard | 108 (57.1) | 60 (55.0) | |
Main pancreatic duct diameter (mm) | 3.1 ± 1.0 | 3.2 ± 1.1 | 0.496 |
Biliary tract compression | 23 (12.2%) | 15 (13.8) | 0.691 |
Pancreaticojejunostomy anastomosis | 0.061 | ||
Duct-to-mucosa | 153 (81.0) | 78 (71.6) | |
Dunking method | 36 (19.0) | 31 (28.4) | |
Pancreatic duct stent | 0.735 | ||
Internal stent | 85 (45.0) | 50 (45.9) | |
External stent | 68 (36.0) | 35 (32.1) | |
None | 36 (19.0) | 24 (22.0) | |
Vascular invasion | 0.483 | ||
Yes | 32 (16.9) | 22 (20.2) | |
No | 157 (83.1) | 87 (79.8) | |
Operative time (min) | 269.5 ± 70.3 | 255.4 ± 64.7 | 0.088 |
Estimated blood loss (mL) | 320.3 ± 269.3 | 326.6 ± 267.5 | 0.846 |
Serum albumin POD 1 (g/L) | 33.01 ± 5.4 | 33.4 ± 5.7 | 0.623 |
Serum globulin on POD 1 (g/L) | 23.4 ± 10.9 | 26.1 ± 27.2 | 0.233 |
Hemoglobin on POD 1 (g/L) | 112.0 ± 16.8 | 112.4 ± 15.8 | 0.849 |
- Citation: Li Y, Zhou F, Zhu DM, Zhang ZX, Yang J, Yao J, Wei YJ, Xu YL, Li DC, Zhou J. Novel risk scoring system for prediction of pancreatic fistula after pancreaticoduodenectomy. World J Gastroenterol 2019; 25(21): 2650-2664
- URL: https://www.wjgnet.com/1007-9327/full/v25/i21/2650.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i21.2650